Clinical study I: Body Weight, Metabolic, and Immune Responses to Metreleptin Versus Placebo Treatment in Obese Hyperleptinemic Subjects with Diabetes No Differential Activation of MAPK Signaling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback